Benchmarking Outcomes for Definitive Treatment of Young-Onset, Locally Advanced Rectal Cancer
- 9 October 2021
- journal article
- research article
- Published by Elsevier BV in Clinical Colorectal Cancer
- Vol. 21 (1), e28-e37
- https://doi.org/10.1016/j.clcc.2021.09.012
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute
This publication has 33 references indexed in Scilit:
- Young Age Increases Risk of Lymph Node Positivity in Early-Stage Rectal CancerJNCI Journal of the National Cancer Institute, 2015
- Chemoradiation, surgery and adjuvant chemotherapy versus induction chemotherapy followed by chemoradiation and surgery: long-term results of the Spanish GCR-3 phase II randomized trialAnnals of Oncology, 2015
- Overtreatment of Young Adults With Colon CancerJAMA Surgery, 2015
- Modern multidisciplinary treatment of rectal cancer based on staging with magnetic resonance imaging leads to excellent local control, but distant control remains a challengeEuropean Journal of Cancer, 2013
- Randomized Trial of Short-Course Radiotherapy Versus Long-Course Chemoradiation Comparing Rates of Local Recurrence in Patients With T3 Rectal Cancer: Trans-Tasman Radiation Oncology Group Trial 01.04Journal of Clinical Oncology, 2012
- Preoperative Versus Postoperative Chemoradiotherapy for Locally Advanced Rectal Cancer: Results of the German CAO/ARO/AIO-94 Randomized Phase III Trial After a Median Follow-Up of 11 YearsJournal of Clinical Oncology, 2012
- Neoadjuvant Treatment Response As an Early Response Indicator for Patients With Rectal CancerJournal of Clinical Oncology, 2012
- Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trialThe Lancet Oncology, 2011
- Young-Onset Rectal Cancer: Presentation, Pattern of Care and Long-term Oncologic Outcomes Compared to a Matched Older-Onset CohortAnnals of Surgical Oncology, 2011
- Preoperative versus Postoperative Chemoradiotherapy for Rectal CancerThe New England Journal of Medicine, 2004